The store will not work correctly when cookies are disabled.
1-(cyclobutylmethyl)-6-(4-fluoro-3-methylphenyl)-1H-pyrrolo[3,2-b]pyridine
ID: ALA4537967
PubChem CID: 124176024
Max Phase: Preclinical
Molecular Formula: C19H19FN2
Molecular Weight: 294.37
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: Cc1cc(-c2cnc3ccn(CC4CCC4)c3c2)ccc1F
Standard InChI: InChI=1S/C19H19FN2/c1-13-9-15(5-6-17(13)20)16-10-19-18(21-11-16)7-8-22(19)12-14-3-2-4-14/h5-11,14H,2-4,12H2,1H3
Standard InChI Key: MTXPFYDPXWYSJL-UHFFFAOYSA-N
Molfile:
RDKit 2D
22 25 0 0 0 0 0 0 0 0999 V2000
25.1912 -16.5460 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.1900 -17.3656 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.8981 -17.7745 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.8963 -16.1372 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
26.6049 -16.5424 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.6097 -17.3656 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.3941 -17.6154 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
27.8741 -16.9466 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.3863 -16.2835 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.4820 -17.7736 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.7762 -17.3630 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.0687 -17.7704 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.0676 -18.5884 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.7800 -18.9974 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.4846 -18.5877 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.7822 -19.8146 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.3601 -18.9974 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
27.6512 -18.3911 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.4515 -18.5564 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.8980 -19.2403 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.5807 -18.7912 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.1317 -18.1085 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 1 0
8 9 2 0
9 5 1 0
2 10 1 0
10 11 2 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 10 1 0
14 16 1 0
13 17 1 0
7 18 1 0
18 19 1 0
19 20 1 0
20 21 1 0
21 22 1 0
22 19 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 294.37 | Molecular Weight (Monoisotopic): 294.1532 | AlogP: 4.95 | #Rotatable Bonds: 3 |
Polar Surface Area: 17.82 | Molecular Species: NEUTRAL | HBA: 2 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 2 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 4.30 | CX LogP: 4.99 | CX LogD: 4.99 |
Aromatic Rings: 3 | Heavy Atoms: 22 | QED Weighted: 0.67 | Np Likeness Score: -1.51 |
References
1. Chrovian CC, Soyode-Johnson A, Wall JL, Rech JC, Schoellerman J, Lord B, Coe KJ, Carruthers NI, Nguyen L, Jiang X, Koudriakova T, Balana B, Letavic MA.. (2019) 1H-Pyrrolo[3,2-b]pyridine GluN2B-Selective Negative Allosteric Modulators., 10 (3): [PMID:30891123] [10.1021/acsmedchemlett.8b00542] |